Trial Design: Phase I study to evaluate safety and anti-tumor activity of autologous T cells with alpha-feto protein (AFP(c332T)) receptor in patients with advanced hepatocellular carcinoma (HCC)
HEPATOLOGY(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要